Brainstorm Cell Therapeutics Inc (BCLI)

Brainstorm Cell Therapeutics Inc Azioni (BCLI) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Research and Development	43.40% 0.961	1.698	3.33	2.794	2.924
Operating Income/Loss	48.50% -2.474	-4.804	-6.035	-5.449	-5.151
Income/Loss From Continuing Operations Before Tax	39.03% -3.401	-5.578	-1.226	-5.329	-5.059
Income/Loss From Continuing Operations After Tax	39.03% -3.401	-5.578	-1.226	-5.329	-5.059
Net Income/Loss	39.03% -3.401	-5.578	-1.226	-5.329	-5.059
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,195% 64.74	2.8204	44.25	39.70	36.74
Diluted Average Shares	2,195% 64.74	2.8204	44.25	39.70	36.74
Basic Earnings Per Share	54.55% -0.05	-0.11	-0.03	-0.13	-0.14
Diluted Earnings Per Share	54.55% -0.05	-0.11	-0.03	-0.13	-0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-